Ignite Creation Date:
2025-12-24 @ 2:08 PM
Ignite Modification Date:
2026-04-13 @ 9:44 AM
Study NCT ID:
NCT03085095
Status:
COMPLETED
Last Update Posted:
2022-01-18
First Post:
2017-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer
Sponsor:
Myovant Sciences GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-18
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-26
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-09
First Submit QC Date:
None
Study First Post Date:
2017-03-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-01-19
Results First Submit QC Date:
None
Results First Post Date:
2021-03-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-03-25
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-01-06
Last Update Post Date:
2022-01-18
Last Update Post Date Type:
ACTUAL